Impact of Epitact® Light Legs phlebological insoles on symptoms and quality of life in patients with chronic venous disease - 26/03/26
, Tom Lecocq c, Axelle Thibert d, Laurent Mourot b, e, f, Nicolas Tordi b, cAbstract |
Background |
The management of chronic venous disease is based on the targeted treatment of the arch of the foot and the gait. Epitact ® Light Legs phlebological insoles is a medical device designed to stimulate and optimize venous return in patients with chronic venous disease.
Method |
Semell’Innov is a prospective, randomized controlled, two-arm single center study. The goal was to measure the impact of insoles on symptoms (VEINES-QOL/Sym) and quality of life (CIVIQ14) in patients with stage C2S chronic venous disease (CEAP classification – Clinical C, Etiological E, Anatomical A, and Pathophysiological P). Forty-six subjects were evaluated for two months, during which they randomly used either their usual non-phlebological insoles or phlebological insoles.
Result |
Our data showed that wearing phlebological insoles led to a reduction in symptoms (VEINES-QOL/Sym score – inclusion visit: 35.6 ± 6.9; usual non-phlebological insoles: 38.7 ± 6.5; phlebological insoles: 45.1 ± 5.5; P < 0.001) and improved quality of life (CIVIQ14 score – inclusion visit: 19.8 ± 16.3; usual non-phlebological insoles: 13.9 ± 12.6; phlebological insoles: 8.0 ± 11.1; P < 0.001).
Conclusion |
These results suggest that the use of the Epitact ® Light Legs phlebological insoles may have a beneficial effect on the symptoms and quality of life of patients with chronic venous disease.
Le texte complet de cet article est disponible en PDF.Keywords : Quality of life, Chronic venous disease, Phlebological insoles
Plan
Vol 51 - N° 2
P. 70-76 - avril 2026 Retour au numéro
Article précédent
- Stroke-related mortality in Mahajanga, Madagascar in 2019: A study based on death notifications
- Odilon Rahamefy Randrianasolo, Lala Andriamasinavalona Rajaonarison, Nomena Finiavana Rasaholiarison, Jenny Larissa Rakotomanana, Julien Razafimahefa, Noel Zodaly, Alain Djacoba Tehindrazanarivelo
- How French vascular physicians treat cancer associated superficial vein thrombosis?
- Simon Soudet, Lina Khider, Tristan Mirault, Florian Scotté, Laurent Bertoletti, Marie-Antoinette Sevestre
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?